NCT00714844已完成不适用
Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin
University of Roma La Sapienza0 个研究点目标入组 20 人开始时间: 2007年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Duration of type 2 diabetes for at least 12 months
- •BMI <40 kg/m2
- •HbA1c >7.5%
- •Requiring basal insulin replacement and previously treated with NPH insulin
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Insulin Detemir in Obesity ManagementDiabetesObesityNCT01239550Vanderbilt University240
已完成
4 期
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyDiabetesDiabetes Mellitus, Type 2NCT01966978University of Texas Southwestern Medical Center157
已完成
不适用
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®DiabetesDiabetes Mellitus, Type 2NCT00658099Novo Nordisk A/S699
已完成
4 期
Levemir-Body Composition and Energy MetabolismType 2 DiabetesNCT00862875Institut de Recherches Cliniques de Montreal42
终止
4 期
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00506662Novo Nordisk A/S86